Oral glucose-stimulated serum C-peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment
about
Oral glucose-stimulated serum C-peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Oral glucose-stimulated serum ...... diabetes and renal impairment
@ast
Oral glucose-stimulated serum ...... diabetes and renal impairment
@en
Oral glucose-stimulated serum ...... diabetes and renal impairment
@nl
type
label
Oral glucose-stimulated serum ...... diabetes and renal impairment
@ast
Oral glucose-stimulated serum ...... diabetes and renal impairment
@en
Oral glucose-stimulated serum ...... diabetes and renal impairment
@nl
prefLabel
Oral glucose-stimulated serum ...... diabetes and renal impairment
@ast
Oral glucose-stimulated serum ...... diabetes and renal impairment
@en
Oral glucose-stimulated serum ...... diabetes and renal impairment
@nl
P2093
P2860
P356
P1476
Oral glucose-stimulated serum ...... diabetes and renal impairment
@en
P2093
Atsunori Kashiwagi
Hiroshi Maegawa
Hisazumi Araki
Keiji Isshiki
Shin-Ichi Araki
Shinji Kume
Syohei Yoshida
Takashi Uzu
Yoshikata Morita
Yuki Tanaka
P2860
P304
P356
10.1111/JDI.12169
P577
2013-11-28T00:00:00Z